Skip to content

PARATEK PHARMACEUTICALS, INC.: filings

Every PARATEK PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 50 filings, each linked to its SEC index.

Filing record ends 2023-08-03

The latest filing in this captured record is a 10-Q filed 2023-08-03. No later filing is in the SEC companyfacts record captured on 2026-09-22. PARATEK PHARMACEUTICALS, INC. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-08-03fiscal Q2 2023401170001628280-23-027035
10-Q2023-05-09fiscal Q1 202339810001628280-23-016814
10-K2023-03-16fiscal FY 202244880001628280-23-008187
10-Q2022-11-03fiscal Q3 2022391150001178711-22-000016
10-Q2022-08-03fiscal Q2 2022411170001178711-22-000011
10-Q2022-05-04fiscal Q1 202240830001178711-22-000006
10-K2022-03-14fiscal FY 2021431150001564590-22-009957
10-Q2021-11-08fiscal Q3 2021361000001564590-21-055249
10-Q2021-08-09fiscal Q2 2021421180001564590-21-042629
10-Q2021-05-17fiscal Q1 202137740001564590-21-028178
10-K2021-03-29fiscal FY 2020431150001564590-21-016154
10-Q2020-11-05fiscal Q3 2020381020001564590-20-051367
10-Q2020-08-10fiscal Q2 2020401010001564590-20-038591
10-Q2020-05-11fiscal Q1 202040790001564590-20-023825
10-K2020-03-10fiscal FY 2019431160001564590-20-009802
10-Q2019-11-12fiscal Q3 2019401090001564590-19-042902
10-Q2019-08-06fiscal Q2 2019401040001564590-19-029353
10-Q2019-05-08fiscal Q1 201940780001564590-19-017306
10-K2019-03-06fiscal FY 2018351050001564590-19-006315
10-Q2018-11-06fiscal Q3 201836910001564590-18-027389
10-Q2018-08-02fiscal Q2 201836920001564590-18-018613
10-Q2018-05-09fiscal Q1 201830620001564590-18-012027
10-K2018-03-06fiscal FY 2017321030001564590-18-004551
10-Q2017-11-08fiscal Q3 201729740001564590-17-022400
10-Q2017-08-02fiscal Q2 201729740001564590-17-014727
10-Q2017-05-04fiscal Q1 201727550001564590-17-008487
10-K2017-03-02fiscal FY 2016311000001564590-17-003144
10-Q2016-11-02fiscal Q3 201626650001564590-16-026824
10-Q2016-08-04fiscal Q2 201626650001564590-16-022461
10-Q2016-05-02fiscal Q1 201626520001564590-16-017306
10-K2016-03-09fiscal FY 201528910001564590-16-014314
10-Q2015-11-12fiscal Q3 201524580001564590-15-010451
10-Q2015-08-11fiscal Q2 201524590001564590-15-006937
10-Q2015-05-15fiscal Q1 201521420001193125-15-190442
10-K/A2015-04-24fiscal FY 201426480001193125-15-146277
10-K2015-04-02fiscal FY 201426480001193125-15-117033
10-Q2014-10-28fiscal Q3 201425650001178711-14-000065
10-Q2014-08-06fiscal Q2 201425650001178711-14-000038
10-Q2014-05-05fiscal Q1 201425530001178711-14-000018
10-K2014-03-14fiscal FY 2013351500001178711-14-000011
10-Q2013-11-07fiscal Q3 201330830001178711-13-000059
10-Q2013-08-08fiscal Q2 201326660001178711-13-000038
10-Q2013-05-09fiscal Q1 201326540001178711-13-000027
10-K2013-03-12fiscal FY 2012371720001178711-13-000012
10-Q2012-11-13fiscal Q3 201233860001193125-12-467444
10-Q2012-08-13fiscal Q2 201230740001193125-12-352475
10-Q2012-05-15fiscal Q1 201228570001193125-12-233906
10-K2012-03-30fiscal FY 201131810001193125-12-143822
10-Q2011-11-10fiscal Q3 201128680001193125-11-307075
10-Q2011-08-15fiscal Q2 201128680001193125-11-222824

Inspect the source

Entity
PARATEK PHARMACEUTICALS, INC. / CIK 0001178711
Captured
SEC response SHA-256
dbc9d1f5ee56873bed348d370e7ea491d77396063452f508c16a516d0d8ad195

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001178711.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))